Prabhudas Lilladher has come out with its second quarter (July-September’ 21) earnings estimates for the Pharma sector. The brokerage house expects Thyrocare Technologies to report net profit at Rs 41.8 crore down 2.9% year-on-year (down 25.4% quarter-on-quarter).
Net Sales are expected to increase by 1.6 percent Y-o-Y (down 5.7 percent Q-o-Q) to Rs 155.6 crore, according to Prabhudas Lilladher.
Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to (down 13.6 percent Q-o-Q) to Rs 61.9 crore.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Read More
